Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Wenkang Luan, Yao Qian, Xin Ni, Xuefeng Bu, Yun Xia, Jinlong Wang, Hongru Ruan, Shaojun Ma & Bin Xu. (2017) miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma. OncoTargets and Therapy 10, pages 1237-1246.
Read now
Read now
Articles from other publishers (25)
Daniel C Sasson, John T Smetona, Yassmin Parsaei, Marianna Papageorge, Stephan Ariyan, Kelly Olino & James Clune. (2023) Malignant Melanoma in Older Adults: Different Patient or Different Disease?. Cureus.
Crossref
Crossref
Erica Mark, Mira Sridharan, Brian Florenzo, Olivia L Schenck, Mary-Margaret B Noland, John S Barbieri & Jules B Lipoff. (2022) Crowdsourcing Medical Costs in Dermatology: Cross-sectional Study Analyzing Dermatologic GoFundMe Campaigns. JMIR Dermatology 5:2, pages e34111.
Crossref
Crossref
Md. Mominur Rahman, Md. Saidur Rahaman, Md. Rezaul Islam, Firoza Rahman, Faria Mannan Mithi, Taha Alqahtani, Mohannad A. Almikhlafi, Samia Qasem Alghamdi, Abdullah S Alruwaili, Md. Sohel Hossain, Muniruddin Ahmed, Rajib Das, Talha Bin Emran & Md. Sahab Uddin. (2021) Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects. Molecules 27:1, pages 233.
Crossref
Crossref
Lei Wang, Junshen Wu, Zhibing Dai, Suzhi Ji & Renbing Jiang. (2021) Clinical characteristics and prognosis of acral lentiginous melanoma: a single‐center series of 211 cases in China. International Journal of Dermatology 60:12, pages 1504-1509.
Crossref
Crossref
Donatella Iacono, Maria Grazia Vitale, Debora Basile, Giacomo Pelizzari, Marika Cinausero, Elena Poletto, Gaetano Pascoletti & Alessandro Marco Minisini. (2020) Immunotherapy for older patients with melanoma: From darkness to light?. Pigment Cell & Melanoma Research 34:3, pages 550-563.
Crossref
Crossref
Shijian Xiang, Haiyan Zeng, Fan Xia, Qiufeng Ji, Jianwen Xue, Ruxia Ren, Fuchang Que & Benjie Zhou. (2021) The dietary flavonoid isoliquiritigenin induced apoptosis and suppressed metastasis in melanoma cells: An in vitro and in vivo study. Life Sciences 264, pages 118598.
Crossref
Crossref
Hyun Ji Kang, Myoung Eun Choi, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee, Jee Ho Choi & Woo Jin Lee. (2020) Clinicoprognostic characteristics of cutaneous metastatic melanoma: a retrospective comparative study between acral and nonacral melanoma. International Journal of Dermatology 59:10, pages 1249-1257.
Crossref
Crossref
Parisa Sahranavardfard, Javad Firouzi, Masoumeh Azimi, Pardis Khosravani, Raheleh Heydari, Amirnader Emami Razavi, Mahshad Dorraj, Faezeh Keighobadi & Marzieh Ebrahimi. (2019) MicroRNA‐203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo. Journal of Cellular Physiology 234:11, pages 20193-20205.
Crossref
Crossref
Wenkang Luan, Xuanfeng Zhang, Hongru Ruan, Jinlong Wang & Xuefeng Bu. (2019) Long noncoding RNA OIP5‐AS1 acts as a competing endogenous RNA to promote glutamine catabolism and malignant melanoma growth by sponging miR‐217. Journal of Cellular Physiology 234:9, pages 16609-16618.
Crossref
Crossref
Jian Yuan, Lei Jiang & Chaotang Guo. (2019) The micro RNA hsa-miR-377-3p inhibits tumor growth in malignant melanoma. RSC Advances 9:33, pages 19057-19064.
Crossref
Crossref
Esther Bastiaannet, Nicolò Battisti, Kah Poh Loh, Nienke de Glas, Enrique Soto-Perez-de-Celis, Capucine Baldini, Ellen Kapiteijn & Stuart Lichtman. (2019) Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paper. Journal of Geriatric Oncology 10:3, pages 389-397.
Crossref
Crossref
Guy Ben-Betzalel, Yael Steinberg-Silman, Ronen Stoff, Nethanel Asher, Ronnie Shapira-Frommer, Jacob Schachter & Gal Markel. (2019) Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients. European Journal of Cancer 108, pages 61-68.
Crossref
Crossref
Shijian Xiang, Huoji Chen, Xiaojun Luo, Baichao An, Wenfeng Wu, Siwei Cao, Shifa Ruan, Zhuxian Wang, Lidong Weng, Hongxia Zhu & Qiang Liu. (2018) Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Wenkang Luan, Yan Shi, Zhou Zhou, Yun Xia & Jinlong Wang. (2018) circRNA_0084043 promote malignant melanoma progression via miR-153-3p/Snail axis. Biochemical and Biophysical Research Communications 502:1, pages 22-29.
Crossref
Crossref
Laura Atzori, Caterina Ferreli & Franco Rongioletti. (2018) Diagnostic challenges in the mature patient: Growing old gracefully. Clinics in Dermatology 36:2, pages 116-127.
Crossref
Crossref
Yong Tang, Chao Xie, Yu Zhang, You Qin & Weikang Zhang. (2018) Overexpression of mRNA-decapping enzyme 1a predicts disease-specific survival in malignant melanoma. Melanoma Research 28:1, pages 30-36.
Crossref
Crossref
Wenkang Luan, Zhou Zhou, Yan Zhu, Yun Xia, Jinlong Wang & Bin Xu. (2018) miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase. Biochemical and Biophysical Research Communications 495:1, pages 46-52.
Crossref
Crossref
Joyce Y. Cheng & Oscar R. Colegio. 2018. Skin Diseases in the Immunosuppressed. Skin Diseases in the Immunosuppressed
185
202
.
Wenkang Luan, Rubo Li, Liang Liu, Xin Ni, Yan Shi, Yun Xia, Jinlong Wang, Feng Lu & Bin Xu. (2017) Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p. Oncotarget 8:49, pages 85401-85414.
Crossref
Crossref
Simone Garcovich, Giuseppe Colloca, Pietro Sollena, Bellieni Andrea, Lodovico Balducci, William C. Cho, Roberto Bernabei & Ketty Peris. (2017) Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology. Aging and disease 8:5, pages 643.
Crossref
Crossref
Sarah A. Weiss, Joseph Han, Farbod Darvishian, Jeremy Tchack, Sung Won Han, Karolina Malecek, Michelle Krogsgaard, Iman Osman & Judy Zhong. (2016) Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts. Journal of Translational Medicine 14:1.
Crossref
Crossref
C.M. Madronio, B.K. Armstrong, C.G. Watts, C. Goumas, R.L. Morton, A. Curtin, S.W. Menzies, G.J. Mann, J.F. Thompson & A.E. Cust. (2016) Doctors’ recognition and management of melanoma patients’ risk: An Australian population-based study. Cancer Epidemiology 45, pages 32-39.
Crossref
Crossref
Jia Yu, Xue Luo, Hui Huang, Zhifang Zhai, Zhu Shen & Hui Lin. (2016) Clinical Characteristics of Malignant Melanoma in Southwest China: A Single-Center Series of 82 Consecutive Cases and a Meta-Analysis of 958 Reported Cases. PLOS ONE 11:11, pages e0165591.
Crossref
Crossref
Feng Su, Yifei Chen, Shilin Zhu, Fangfang Li, Shuang Zhao, Lisa Wu, Xiang Chen & Juan Su. (2016) RAB22A overexpression promotes the tumor growth of melanoma. Oncotarget 7:44, pages 71744-71753.
Crossref
Crossref
Romany A. Johnpulle, Igor Puzanov & Douglas B. Johnson. (2016) Treatment of elderly patients with melanoma. memo - Magazine of European Medical Oncology 9:1, pages 13-16.
Crossref
Crossref